Pfizer ups offer to acquire fellow drugmaker AstraZeneca for third time, to $119 billion

  • by: LINDA A. JOHNSON , Associated Press
  • Updated: May 18, 2014 - 8:50 PM

NEW YORK — U.S. drugmaker Pfizer said Sunday that it has raised its offer for British rival AstraZeneca for a third time, hiking its stock-and-cash offer by 15 percent to $118.8 billion, or 70.73 billion pounds.

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT